UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): June 19, 2003
BIOANALYTICAL
SYSTEMS, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Indiana
|
|
0-23357
|
|
35-1345024
|
(State
or other jurisdiction of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.)
|
2701
KENT AVENUE
WEST
LAFAYETTE, INDIANA
|
|
47906-1382
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (765) 463-4527
Item
5.02.
|
Departure
of Directors or Certain Officers; Election of Directors;
Appointment
of Certain Officers; Compensatory Arrangements of
Certain
Officers.
|
On
June
19, 2003, Bioanalytical Systems, Inc. (the "Company") entered into a letter
agreement with then Chief Operating Officer Ronald E. Shoup, Ph.D. Under Dr.
Shoup's agreement, if Dr. Shoup's employment is terminated for any reason other
than Just Cause, as defined in the agreement, at any time during a two-year
period following a Significant Transaction or Change in Board Composition,
each
as defined in the agreement, Dr. Shoup is entitled to receive his annual base
salary one month for each year of service with the Company from the date of
termination.
The
foregoing description of the Letter Agreement is qualified in its entirety
by
reference to the Letter Agreement, which is filed as Exhibit 10.1 to this report
and which is incorporated herein by reference.
Item
9.01. Financial
Statements and Exhibits.
(a) Not
applicable.
(b) Not
applicable.
(c) Not
Applicable
(d) Exhibit
|
10.1
|
Letter
Agreement between Bioanalytical Systems, Inc. and Ronald E. Shoup,
Ph.D.,
dated June 19, 2003.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
Bioanalytical Systems, Inc. |
|
|
|
Date: July
24, 2007 |
By: |
/s/ Michael
R. Cox |
|
Michael
R. Cox |
|
Vice
President, Finance and Chief Financial
Officer |
Exhibit
Index
10.1 |
Letter
Agreement between Bioanalytical Systems, Inc. and Ronald E. Shoup,
Ph.D.,
dated June 19, 2003. |